GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Y

Youcare Pharmaceutical Group Co 688658.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

11.45

-0.43%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥2.45bn

FY2017FY2025

Net income

−CN¥253.8m

FY2017FY2025

Free cash flow

CN¥208.9m

FY2017FY2025

Shareholders' equity

CN¥3.32bn

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueCN¥2.45bnCN¥3.78bnCN¥4.20bnCN¥4.54bnCN¥4.97bnCN¥4.34bnCN¥4.29bnCN¥3.98bnCN¥2.70bn
Research and developmentCN¥441.2mCN¥374.3mCN¥351.9mCN¥344.4mCN¥200.0mCN¥127.9mCN¥126.2mCN¥98.1mCN¥81.7m
Operating income−CN¥228.0mCN¥159.1mCN¥231.8mCN¥357.9mCN¥636.8mCN¥518.7mCN¥364.5mCN¥323.4mCN¥188.9m
Net income−CN¥253.8mCN¥123.7mCN¥184.8mCN¥335.2mCN¥545.3mCN¥442.1mCN¥285.5mCN¥267.9mCN¥161.6m
Diluted earnings per share-0.540.290.400.711.211.210.800.570.35

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsCN¥5.21bnCN¥5.74bnCN¥5.91bnCN¥6.01bnCN¥5.73bnCN¥5.46bnCN¥3.47bnCN¥3.42bnCN¥3.50bn
Cash and short-term investmentsCN¥1.42bnCN¥1.49bnCN¥1.48bnCN¥1.66bnCN¥2.44bnCN¥2.53bnCN¥394.7mCN¥301.6mCN¥792.4m
Total liabilitiesCN¥1.77bnCN¥2.15bnCN¥2.31bnCN¥2.01bnCN¥1.80bnCN¥1.87bnCN¥2.34bnCN¥2.58bnCN¥2.79bn
DebtCN¥738.3mCN¥644.4mCN¥462.9mCN¥277.8mCN¥37.6mCN¥201.6mCN¥524.4mCN¥466.5mCN¥853.0m
Shareholders' equityCN¥3.32bnCN¥3.58bnCN¥3.59bnCN¥3.99bnCN¥3.92bnCN¥3.58bnCN¥1.12bnCN¥835.5mCN¥705.6m
Shares outstanding468m429m459m470m453m365m357m468m468m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operationsCN¥344.0mCN¥438.2mCN¥785.5m−CN¥121.2mCN¥515.2mCN¥697.7mCN¥324.9mCN¥192.7mCN¥214.8m
Capital spending−CN¥135.1m−CN¥358.6m−CN¥497.5m−CN¥548.0m−CN¥200.5m−CN¥126.7m−CN¥148.0m−CN¥173.8m−CN¥105.3m
Free cash flowCN¥208.9mCN¥79.6mCN¥288.0m−CN¥669.1mCN¥314.8mCN¥570.9mCN¥176.9mCN¥18.9mCN¥109.5m
Dividends paid−CN¥23.2m−CN¥111.2m−CN¥495.0m−CN¥306.0m−CN¥202.5m−CN¥22.2m−CN¥25.8m−CN¥31.1m−CN¥392.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥625.1mCN¥556.0mCN¥687.0mCN¥591.7mCN¥590.0mCN¥577.4mCN¥789.1mCN¥1.04bn
Operating income−CN¥4.9m−CN¥17.5m−CN¥83.8m−CN¥57.0m−CN¥48.2m−CN¥55.4m−CN¥93.5mCN¥110.3m
Net income−CN¥71.8m−CN¥33.1m−CN¥105.9m−CN¥49.1m−CN¥49.6m−CN¥49.3m−CN¥86.0mCN¥91.2m
Diluted earnings per share-0.15-0.07-0.23-0.11-0.11-0.11-0.200.21
Cash from operations——CN¥173.0mCN¥176.0m−CN¥88.0mCN¥81.0mCN¥7.0mCN¥188.0m
Capital spending−CN¥24.0m−CN¥26.0m−CN¥18.0m−CN¥32.0m−CN¥27.0m−CN¥57.0m−CN¥100.0m−CN¥75.0m
Free cash flow——CN¥155.0mCN¥144.0m−CN¥115.0mCN¥24.0m−CN¥93.0mCN¥113.0m
Total assetsCN¥5.05bnCN¥5.19bnCN¥5.21bnCN¥5.23bnCN¥5.29bnCN¥5.61bnCN¥5.74bnCN¥6.00bn
Cash and short-term investments——CN¥1.42bnCN¥1.35bnCN¥1.24bnCN¥1.56bnCN¥1.49bnCN¥1.60bn
DebtCN¥474.5mCN¥492.1mCN¥734.5mCN¥472.7mCN¥431.3mCN¥641.2mCN¥629.9mCN¥648.4m
Shareholders' equityCN¥3.21bnCN¥3.28bnCN¥3.32bnCN¥3.43bnCN¥3.48bnCN¥3.53bnCN¥3.58bnCN¥3.66bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-18.6%-10.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-41.749.951.827.124.720.1
Price to sales4.31.62.32.02.72.0

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 25 Jun 2024.

FY2024FY2023FY2022FY2021
Paid in the year0.201.100.680.45

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.